Article Details
Retrieved on: 2021-03-08 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche plans to advance prasinezumab into the Phase 2b PADOVA study in patients with early Parkinson's disease in the second quarter 2021. All three ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here